Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytes

Regulatory Peptides

Volumn 135, Issue 1-2, 2006, Pages 12-16

  Kralisch, Susan ^a   Klein, Johannes ^b   Lossner, Ulrike ^a   Bluher, Matthias ^a   Paschke, Ralf ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

3T3 L1 adipocyte; Insulin resistance; Isoproterenol; MCP 1; Obesity

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CELL STRAIN 3T3; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MESSENGER RNA SYNTHESIS; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE;

3T3 CELLS; ADENYLATE CYCLASE; ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FORSKOLIN; ISOPROTERENOL; MICE; RNA, MESSENGER;

EID: 33744543397     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.03.002     Document Type: Article

References (33)

1. Fasshauer M., and Paschke. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
2. Sartipy P., and Loskutoff. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100 (2003) 7265-7270
3. Sell H., Dietze-Schroeder, Uhlig, and Eckel. MCP-1 exerts a key function in the negative crosstalk between adipose tissue and skeletal muscle in humans. Diabetes Supplement 1 (2005) 1321-P
4. Bruun J.M., Lihn, Pedersen, and Richelsen. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90 (2005) 2282-2289
5. Simeoni E., Hoffmann, Winkelmann, Ruiz, Fleury, Boehm, Marz, and Vassalli. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47 (2004) 1574-1580
6. Reaven G.M., Lithell, and Landsberg. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334 (1996) 374-381
7. Hoieggen A., Fossum, Nesbitt, Palmieri, and Kjeldsen. Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica. Blood Press 9 (2000) 83-90
8. Facchini F.S., Stoohs, and Reaven. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9 (1996) 1013-1017
9. Maison P., Byrne, Hales, and Wareham. Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous and the metabolic syndrome?. Metabolism 49 (2000) 81-87
10. Kralisch S., Klein, Lossner, Bluher, Paschke, Stumvoll, and Fasshauer. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289 (2005) E586-E590
11. Fasshauer M., Klein, Kralisch, Klier, Lossner, Bluher, and Paschke. Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 317 (2004) 598-604
12. Laborda J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19 (1991) 3998
13. Weisberg S.P., McCann, Desai, Rosenbaum, Leibel, and Ferrante. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
14. Xu H., Barnes, Yang, Tan, Yang, Chou, Sole, Nichols, Ross, Tartaglia, and Chen. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
15. Wellen K.E., and Hotamisligil. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
16. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
17. Gerhardt C.C., Romero, Cancello, Camoin, and Strosberg. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175 (2001) 81-92
18. Bartoli C., Civatte, Pellissier, and Figarella-Branger. CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies. Acta Neuropathol (Berl.) 102 (2001) 385-392
19. Dietze-Schroeder D., Sell, Uhlig, Koenen, and Eckel. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 54 (2005) 2003-2011
20. Bluher M., Windgassen, and Paschke. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. Diabetes Care 23 (2000) 1591-1592
21. Klein J., Fasshauer, Benito, and Kahn. Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression. Mol Endocrinol 14 (2000) 764-773
22. Klein J., Fasshauer, Ito, Lowell, Benito, and Kahn. Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 274 (1999) 34795-34802
23. Kirsch D.M., Baumgarten, Deufel, Rinninger, Kemmler, and Haring. Catecholamine-induced insulin resistance of glucose transport in isolated rat adipocytes. Biochem J 216 (1983) 737-745
24. Arsenis G., and Livingston. Isoproterenol reduces insulin stimulation of hexose uptake by rat adipocytes via a postinsulin binding alteration. Endocrinology 119 (1986) 50-57
25. Patti M.E. Nutrient modulation of cellular insulin action. Ann N Y Acad Sci 892 (1999) 187-203
26. Fasshauer M., Klein, Neumann, Eszlinger, and Paschke. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507 (2001) 142-146
27. Kralisch S., Klein, Lossner, Bluher, Paschke, Stumvoll, and Fasshauer. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185 (2005) R1-R8
28. Fasshauer M., Klein, Lossner, and Paschke. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 35 (2003) 147-152
29. Nomura S., Shouzu, Omoto, Nishikawa, and Fukuhara. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121 (2000) 437-443
30. Collins S., and Surwit. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 56 (2001) 309-328
31. Pai R., Ha, Kirschenbaum, and Kamanna. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J Am Soc Nephrol 7 (1996) 914-923
32. Wuyts W.A., Vanaudenaerde, Dupont, Demedts, and Verleden. Modulation by cAMP of IL-1beta-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells. Eur Respir J 22 (2003) 220-226
33. Nishio Y., Kashiwagi, Takahara, Hidaka, and Kikkawa. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells. Horm Metab Res 29 (1997) 491-495